Listen now | As we’ve seen from the last two years, BioTech holds immense promise for the future, but brings along challenges as an investor into the space. Today we have a lively discussion with two of the biggest minds in BioTech investing, Peter van der Velden, General Partner and Managing director of Lumira Ventures, and Anthony Mouchantaf, Director, Venture Capital at RBCx.